The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2020

Filed:

Jun. 03, 2016
Applicants:

Lead Pharma Holding B.v., Nijmegen, NL;

Sanofi, Paris, FR;

Assignees:

LEAD PHARMA HOLDING B.V., Nijmegen, NL;

SANOFI, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 317/32 (2006.01); C07D 213/81 (2006.01); C07C 311/46 (2006.01); A61P 37/00 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
C07D 213/81 (2013.01); A61P 29/00 (2018.01); A61P 37/00 (2018.01); C07C 311/46 (2013.01); C07C 317/32 (2013.01); C07C 2601/02 (2017.05);
Abstract

Novel compounds according to Formula I or a pharmaceutically acceptable salt thereof wherein: A-Aare N or CR, CR, CR, CR, respectively, with the proviso that no more than two of the four positions A can be simultaneously N; Ris C(2-6)alkyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-3)alkyl, (di)C(3-6)cycloalkylamino or (di)(C(3-6)cycloalkylC(1-3)alkyl)amino; Ris H, hydroxyethyl, methoxyethyl, C(1-6)alkyl, C(6-10)aryl, C(6-10)arylC(1-3)alkyl, C(1-9)heteroaryl, C(1-9)heteroarylC(1-3)alkyl, C(3-6)cycloalkyl, (3-6)cycloalkylC(1-3)alkyl, C(2-5)heterocycloalkyl or C(2-5)heterocycloalkyl-C(1-3)alkyl; the sulfonyl group with Ris represented by one of R, Ror R; Ris H, C(1-6)alkyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-3)alkyl, C(6-10)aryl, C(6-10)arylC(1-3)alkyl, C(1-9)heteroaryl, C(1-9)heteroarylC(1-3)alkyl, C(2-5)heterocycloalkyl or C(2-5)heterocycloalkylC(1-3)alkyl; and Ris C(1-6)alkyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-3)alkyl, C(6-10)aryl, C(6-10)arylC(1-3)alkyl, C(1-9)heteroaryl, C(1-9)heteroarylC(1-3)alkyl, C(2-5)heterocycloalkyl or C(2-5)heterocycloalkylC(1-3)alkyl. The compounds can be used as inhibitors of RORγ and are useful for the treatment of RORγ mediated diseases.


Find Patent Forward Citations

Loading…